Targeting MAPAKAP2(MK2) to combat inflammation by avoiding the differential regulation of anti-inflammatory genes by p38 MAPK inhibitors
Singh, R. K.; Sodhi, R.; Sharma, S.; Dastidar, S. G.; Tandon, R.
Show abstract
p38 mitogen-activated protein kinase (p38 MAPK) plays an important role in the key cellular processes related to inflammation. Several small molecule inhibitors of p38 MAPK therefore have been evaluated for their anti-inflammatory potential and progressed from early discovery to late phase clinical trials. Most of these efforts however have failed due to severe toxicity concerns. Since p38 MAPK has several downstream substrates, inhibition of p38 MAPK, therefore, leads to the modulation of all its substrates, resulting into a dis-balance of pro- and anti-inflammatory response and multiple toxicity concerns. Targeting p38MAPK MAPKAPK2 (MK2), one of the downstream substrates of p38 MAPK directly, is expected to be a better anti-inflammatory approach without having any toxicity concerns. In this manuscript, we are reporting biological data of representative MK2 inhibitor to validate its anti-inflammatory potential and a comparison of p38 MAPK and MK2 inhibitors in cell based assays to understand their relative toxicities.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The wide spectrum anti-inflammatory activity of andrographolide in comparison to NSAIDs: a promising therapeutic compound against the cytokine storm 97%
- A Priori Activation of Apoptosis Pathways of Tumor (AAAPT) Technology: Development of Targeted Apoptosis Initiators for Cancer Treatment. 96%
- Protective Effect of Cannabinoid Type II Receptor Ligand on Bleomycin-Induced Pulmonary Fibrosis in Mice 96%
Similar papers in this journal
- The mitochondrial deubiquitinase USP30 regulates AKT/mTOR signaling 95%
- Innovative, rapid, high throughput method for drug repurposing in a pandemic - a case study of SARS-CoV-2 and COVID-19 94%
- Anti-inflammatory properties of chemical probes in human whole blood: focus on prostaglandin E2 production 93%
Similar papers in this journal
- Novel Peptide Inhibitor of Human Tumor Necrosis Factor-α has Antiarthritic Activity 95%
- The combination of lipopolysaccharide and D-galactosamine administration show positive genotoxic effect in mice liver 95%
- Discovery of Z1362873773: A Novel Fascin Inhibitor from a Large Chemical Library for Colorectal Cancer 94%
Similar papers in this journal
- Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19 94%
- Pro-cognitive Effects of Dual Tacrine Derivatives Acting as Cholinesterase Inhibitors and NMDA Receptor Antagonists 93%
- Characterization of new highly selective pyrazolopyrimidine inhibitor of CDK7 91%
Similar papers in this journal
- Ion transport modulators differentially modulate inflammatory responses in THP-1 derived macrophages 95%
- Enhancement of Macrophage Function by the Antimicrobial Peptide Sublancin Protects Mice from Methicillin-Resistant Staphylococcus aureus 93%
- Design of Epitope Based Peptide Vaccine Against Pseudomonas Aeruginosa Fructose Bisphosphate Aldolase Protein using Immunoinformatics 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.